Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Here’s some good news for you. Remember a few weeks ago I wrote a post about a drug that helps prevent premature births? For years, a generic version was widely available from compounding pharmacies for about $10 per shot, but then, based largely on studies performed by the federal government, Hologic Inc. won approval of a branded version of the drug. It promptly sold the marketing rights to K-V Pharmaceutical, which jacked up the price overnight to about $1,500 per shot:

Then K-V sent letters to pharmacies threatening that the FDA would punish them if they compounded their own versions of the drug. On Wednesday, the FDA declared it would do no such thing.

In its statement, the FDA noted that the drug was important and K-V “received considerable assistance from the federal government in connection with the development of Makena by relying on research funded by the National Institutes of Health to demonstrate the drug’s effectiveness.”

….”In order to support access to this important drug, at this time and under this unique situation, FDA does not intend to take enforcement action against pharmacies that compound [Makena] based on a valid prescription,” the agency said in a statement.

That’s from the Los Angeles Times. It’s not the end of the story, since I assume that K-V will now bring its legal and lobbying muscle to bear in defense of its outrageous pricing. But it’s a good start.

KEEP MOTHER JONES CHARGING HARD

You're busy, so we'll keep this short: We need to raise $325,000 over the next month to help fund the hard-hitting, fiercely independent reporting you get from us. It's a pivotal moment for our democracy, accountability, and so much more—but you already know that, you just read a Mother Jones article. If you can right now, please consider supporting our work with a donation so we're ready for the hard work ahead.

payment methods

KEEP MOTHER JONES CHARGING HARD

You're busy, so we'll keep this short: We need to raise $325,000 over the next month to help fund the hard-hitting, fiercely independent reporting you get from us. It's a pivotal moment for our democracy, accountability, and so much more—but you already know that, you just read a Mother Jones article. If you can right now, please consider supporting our work with a donation so we're ready for the hard work ahead.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate